0000000000067304

AUTHOR

Manuel Fernández-sánchez

0000-0002-1214-2984

showing 8 related works from this author

Elective single versus double embryo transfer: live birth outcome and patient acceptance in a prospective randomised trial

2013

The purpose of this study was to determine which strategy of embryo transfer has a better trade-off in live birth delivery rate versus multiple pregnancy considering patient acceptance: elective single embryo transfer (eSET) or elective double embryo transfer (eDET). In all, 199 women <38 years of age undergoing their first IVF treatment in a private centre were included in a prospective open-label randomised controlled trial. Patients were randomised into four groups: (1) eSET on Day 3; (2) eSET on Day 5; (3) eDET on Day 3; and (4) eDET on Day 5. Per patient, main analysis included acceptance of assigned group, as well as multiple and live birth delivery rates of the fresh cycle. Second…

Adultmedicine.medical_specialtyPregnancy Ratemultiple birth ratemultiple pregnancyFertilization in VitroReproductive technologyBiologyBirth ratelaw.inventionEndocrinologyRandomized controlled trialPregnancylawSingle Embryo TransferGeneticsmedicineHumansProspective Studiesdelivery rateBirth RateMolecular BiologyPregnancyObstetricsPregnancy OutcomeEmbryo culturePatient Acceptance of Health CareEmbryo Transfermedicine.diseaseEmbryo transferPregnancy rateTreatment OutcomeReproductive MedicineFemaleAnimal Science and ZoologyPregnancy MultipleLive birthLive BirthMaternal AgeDevelopmental BiologyBiotechnologyReproduction, Fertility and Development
researchProduct

Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.

2007

Abstract Context: Ovarian hyperstimulation syndrome (OHSS) results from increased vascular permeability (VP) caused by ovarian hypersecretion of vascular endothelial growth factor (VEGF), which activates its receptor-2. In animals, the dopamine receptor 2 agonist cabergoline (Cb2) inactivates VEGF receptor-2 and prevents increased VP. Objective: Our objective was to test whether Cb2 reduces VP and prevents OHSS in humans. Design: We conducted a prospective, randomized, double-blind study on oocyte donors at risk of developing OHSS (>20 follicles, >12 mm developed, and >20 oocytes retrieved). Interventions: Cb2 0.5 mg/d (n = 37) or a placebo (n = 32) was administered fro…

Endocrinology Diabetes and MetabolismClinical BiochemistryOvarian hyperstimulation syndromeVascular permeabilityHematocritBiochemistrychemistry.chemical_compoundHemoglobinsEndocrinologyPregnancyAscitesImage Processing Computer-AssistedMedicineProspective Studiesmedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionObstetrics and GynecologyAscitesGeneral MedicineHemoconcentrationMagnetic Resonance ImagingVascular endothelial growth factorHematocritDopamine AgonistsFemalemedicine.symptommedicine.drugAgonistAdultmedicine.medical_specialtyCabergolinemedicine.drug_classContext (language use)Fertilization in VitroDopamine agonistOvarian Hyperstimulation SyndromeDouble-Blind MethodInternal medicineCabergolineLuteal CellsHumansErgolinesGranulosa Cellsbusiness.industryReceptors Dopamine D2Peritoneal fluidBiochemistry (medical)Ovarymedicine.diseaseEndocrinologychemistryRegional Blood FlowbusinessExtracellular SpaceThe Journal of clinical endocrinology and metabolism
researchProduct

Endometrial study of a novel in vivo embryo culture

2012

In Vivo Development; Intrauterine Device; ProkineticinsProkineticinsIntrauterine DeviceUNESCO::CIENCIAS MÉDICASIn Vivo Development:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Influence of follicle rupture and uterine contractions on intrauterine insemination outcome: a new predictive model.

2014

Objective To correlate the detection of follicle rupture and the number of uterine contractions per minute with the outcome of IUI and to build a predictive model for the outcome of IUI including these parameters. Design Retrospective cohort study. Setting Fertility clinic. Patient(s) We analyzed data from 610 women who underwent homologous or donor double IUI from 2005 to 2010 and whose data of uterine contractions or follicle rupture were recorded. Intervention(s) None. Main Outcome Measure(s) Live-birth rate. Result(s) Nine hundred seventy-nine IUI cycles were included. The detection of follicle rupture (odds ratio [OR], 1.98; 95% confidence interval [CI], 1.30–3.01) and the number of ut…

Ovulationmedicine.medical_specialtyTime Factorsmedia_common.quotation_subjectInseminationUterine contractionFollicleUterine ContractionOvarian FolliclePregnancymedicineOdds RatioHumansOvarian follicleOvulationmedia_commonInsemination Artificial HomologousRetrospective StudiesGynecologyPregnancyChi-Square DistributionModels Statisticalbusiness.industryObstetrics and GynecologyRetrospective cohort studymedicine.diseaseConfidence intervalmedicine.anatomical_structureLogistic ModelsTreatment OutcomeReproductive MedicineMultivariate AnalysisInsemination Artificial HeterologousFemalemedicine.symptombusinessLive BirthFertility and sterility
researchProduct

Deregulation of miR-324/KISS1/kisspeptin in early ectopic pregnancy: mechanistic findings with clinical and diagnostic implications

2019

[Abstract] BACKGROUND: Ectopic pregnancy is a life-threatening condition for which novel screening tools that would enable early accurate diagnosis would improve clinical outcomes. Kisspeptins, encoded by KISS1, play an essential role in human reproduction, at least partially by regulating placental function and possibly embryo implantation. Kisspeptin levels are elevated massively in normal pregnancy and reportedly altered in various gestational pathologic diseases. Yet, the pathophysiologic role of KISS1/kisspeptin in ectopic pregnancy has not been investigated previously. OBJECTIVE: The purpose of this study was to evaluate changes of KISS1/kisspeptin levels in ectopic pregnancy and thei…

BIOMARKERdiagnosisEctopic pregnancyPlacentaUNKNOWN LOCATIONPhysiology0302 clinical medicineKisspeptinPregnancyDiagnosis030212 general & internal medicineKisspeptins030219 obstetrics & reproductive medicineEctopic pregnancyObstetrics & GynecologyObstetrics and GynecologyPregnancy Ectopicmedicine.anatomical_structureectopic pregnancyBiomarker (medicine)GestationFemaleKISSPEPTINLife Sciences & BiomedicineSERUM PROGESTERONEhormones hormone substitutes and hormone antagonistsmiR-324-3pEXPRESSIONDown-RegulationGestational AgeReal-Time Polymerase Chain ReactionVALIDATION03 medical and health sciencesKisspeptinsPlacentamicroRNAmedicineHumansMESSENGER-RNASRNA MessengerObstetrics & Reproductive MedicinePregnancyScience & Technologybusiness.industryDecision TreesKISS 1BiomarkerEmbryo Mammalianmedicine.diseaseMicroRNAsEarly DiagnosisCase-Control Studies1114 Paediatrics and Reproductive MedicineKISS1businessBiomarkers
researchProduct

In vitro fertilization with personalized blastocyst transfer versus frozen or fresh blastocyst transfer: a multicenter, randomized clinical trial

2019

AndrologyIn vitro fertilisationReproductive MedicineRandomized controlled triallawbusiness.industrymedicine.medical_treatmentBlastocyst TransfermedicineObstetrics and Gynecologybusinesslaw.invention
researchProduct

Monozygotic twinning after assisted reproductive technologies: a case report of asymmetric development and incidence during 19 years in an internatio…

2015

Objective To describe a case of monozygotic twinning with asymmetric development following a single fresh embryo transfer as part of an intracytoplasmic sperm injection (ICSI) treatment. Secondarily, to report the incidence of monozygotic twinning at the IVI (Instituto Valenciano de Infertilidad) clinics. Design Case report. Setting Private fertility centers. Patient(s) A 33-year-old woman with a 2-year history of primary infertility. Intervention(s) Controlled ovarian hyperstimulation and ICSI treatment with single-embryo transfer. Main Outcome Measure(s) Incidence of monozygotic twinning at the IVI clinics. Result(s) We report a twin pregnancy after a single-embryo transfer. Twins were di…

AdultMalemedicine.medical_specialtyDatabases FactualReproductive Techniques Assistedmedia_common.quotation_subjectmedicine.medical_treatmentFertilityReproductive technologyControlled ovarian hyperstimulationUltrasonography PrenatalIntracytoplasmic sperm injectionOvulation InductionPredictive Value of TestsPregnancySingle Embryo TransfermedicineHumansGenetic TestingSperm Injections IntracytoplasmicInfertility MaleTwin Pregnancymedia_commonGynecologyPregnancyIn vitro fertilisationTwinning Monozygoticbusiness.industryIncidence (epidemiology)Obstetrics and GynecologyTwins Monozygoticmedicine.diseaseFertilityTreatment OutcomeReproductive MedicinePregnancy TwinFemalebusinessLive BirthFertility and Sterility
researchProduct

Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system.

2006

Objective To summarize the effects of novel hormones (leptin, ghrelin, adiponectin, resistin, and PYY3-36) secreted from adipose tissue and the gastrointestinal tract that have been discovered to exert different effects on several reproductive functions, such as the hypothalamic–pituitary–gonadal axis, embryo development, implantation physiology, and clinically relevant conditions. Design A MEDLINE computer search was performed to identify relevant articles. Result(s) Leptin and ghrelin exert important roles on body weight regulation, eating behavior, and reproduction, acting on the central nervous system and target reproductive organs. As a marker of adequate nutritional stores, these horm…

LeptinMalemedicine.medical_specialtyMEDLINEPeptide HormonesAdipose tissueHypothalamic–pituitary–gonadal axisBiologyGenitalia MaleInternal medicineProtein Interaction MappingmedicineAnimalsHumansPeptide YYResistinReproductive systemGonadal Steroid HormonesReproductive functionEvidence-Based MedicineAdiponectinLeptinReproductiondigestive oral and skin physiologyObstetrics and GynecologyGenitalia FemaleGhrelinPeptide FragmentsGastrointestinal TractEndocrinologyReproductive MedicineAdipose TissueGhrelinFemaleAdiponectinhormones hormone substitutes and hormone antagonistsHormoneSignal TransductionFertility and sterility
researchProduct